A

Arvinas
D

ARVN

7.95000
USD
0.04
(0.51%)
مغلق
حجم التداول
25,762
الربح لكل سهم
-0
العائد الربحي
-
P/E
-12
حجم السوق
580,281,551
أصول ذات صلة
BNTX
BNTX
1.570
(1.45%)
109.800 USD
C
CRSP
0.455
(0.88%)
52.120 USD
F
FATE
0.02000
(1.80%)
1.13000 USD
G
GH
0.270
(0.54%)
50.460 USD
GSK
GSK
-0.285
(-0.74%)
38.220 USD
MRNA
MRNA
0.195
(0.64%)
30.480 USD
PFE
PFE
0.110
(0.43%)
25.440 USD
T
TDOC
-0.05500
(-0.66%)
8.29500 USD
VRTX
VRTX
2.24
(0.49%)
459.27 USD
المزيد
الأخبار المقالات

العنوان: Arvinas

القطاع: Healthcare
الصناعة: Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.